State Street’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $289M | Sell |
|
|||||
|
2025
Q2 | $261M | Sell |
|
|||||
|
2025
Q1 | $273M | Sell |
|
|||||
|
2024
Q4 | $240M | Buy |
|
|||||
|
2024
Q3 | $280M | Sell |
|
|||||
|
2024
Q2 | $264M | Sell |
|
|||||
|
2024
Q1 | $301M | Sell |
|
|||||
|
2023
Q4 | $264M | Sell |
|
|||||
|
2023
Q3 | $258M | Sell |
|
|||||
|
2023
Q2 | $261M | Sell |
|
|||||
|
2023
Q1 | $267M | Buy |
|
|||||
|
2022
Q4 | $263M | Sell |
|
|||||
|
2022
Q3 | $225M | Buy |
|
|||||
|
2022
Q2 | $373M | Sell |
|
|||||
|
2022
Q1 | $397M | Sell |
|
|||||
|
2021
Q4 | $402M | Sell |
|
|||||
|
2021
Q3 | $352M | Sell |
|
|||||
|
2021
Q2 | $370M | Sell |
|
|||||
|
2021
Q1 | $340M | Sell |
|
|||||
|
2020
Q4 | $355M | Buy |
|
|||||
|
2020
Q3 | $358M | Buy |
|
|||||
|
2020
Q2 | $384M | Buy |
|
|||||
|
2020
Q1 | $351M | Buy |
|
|||||
|
2019
Q4 | $433M | Sell |
|
|||||
|
2019
Q3 | $407M | Sell |
|
|||||
|
2019
Q2 | $393M | Sell |
|
|||||
|
2019
Q1 | $412M | Sell |
|
|||||
|
2018
Q4 | $382M | Sell |
|
|||||
|
2018
Q3 | $399M | Sell |
|
|||||
|
2018
Q2 | $403M | Sell |
|
|||||
|
2018
Q1 | $395M | Sell |
|
|||||
|
2017
Q4 | $364M | Sell |
|
|||||
|
2017
Q3 | $419M | Sell |
|
|||||
|
2017
Q2 | $446M | Sell |
|
|||||
|
2017
Q1 | $442M | Sell |
|
|||||
|
2016
Q4 | $408M | Buy |
|
|||||
|
2016
Q3 | $449M | Sell |
|
|||||
|
2016
Q2 | $454M | Buy |
|
|||||
|
2016
Q1 | $420M | Buy |
|
|||||
|
2015
Q4 | $417M | Sell |
|
|||||
|
2015
Q3 | $400M | Sell |
|
|||||
|
2015
Q2 | $437M | Sell |
|
|||||
|
2015
Q1 | $492M | Sell |
|
|||||
|
2014
Q4 | $458M | Sell |
|
|||||
|
2014
Q3 | $496M | Sell |
|
|||||
|
2014
Q2 | $578M | Sell |
|
|||||
|
2014
Q1 | $581M | Sell |
|
|||||
|
2013
Q4 | $583M | Sell |
|
|||||
|
2013
Q3 | $555M | Sell |
|
|||||
|
2013
Q2 | $560M | Buy |
|